ImmUnion
Biotechnology - , ,
ImmUnion Employees
ImmUnion Details
ImmUnion developed the ImmunoTag, a non-toxic molecule able to recruit the anti-tetanus antibodies.We can use these anti-tetanus antibodies for two different goals:Prevention: ImmunoTag can be added to vaccines → VacciTag™ administration to speed-up the vaccination process.Therapy: ImmunoTag can be linked to a tiny antibody → ImmunoJunction™ administration to redirect anti-tetanus antibodies against a virus during infection.
Website:
http://www.preclinics-discovery.com
Employees:
3
HQ:
+49 (0) 331-243433- 50
Location:
, ,
Revenue:
ImmUnion Technologies
Load Balancers
Apache
CMS
WordPress.org
Other
Mobile Friendly